In Vivo Validation Model of a Novel Anti-Inflammatory Scaffold in Interleukin-10 Knockout Mouse
暂无分享,去创建一个
Eugene Lih | D. Han | S. Chun | T. Kwon | J. N. Lee | Y. Ha | H. T. Kim | E. Yoo | Jeongshik Kim | Dae Hwan Kim | B. Kim | Jung Yeon Kim | Sang Hoon Lee | J. Chung | B. I. Jang
[1] K. K. Chereddy,et al. PLGA based drug delivery systems: Promising carriers for wound healing activity , 2016, Wound repair and regeneration : official publication of the Wound Healing Society [and] the European Tissue Repair Society.
[2] A. Lackner,et al. Lack of Interleukin-10-Mediated Anti-Inflammatory Signals and Upregulated Interferon Gamma Production Are Linked to Increased Intestinal Epithelial Cell Apoptosis in Pathogenic Simian Immunodeficiency Virus Infection , 2014, Journal of Virology.
[3] B. Park,et al. Fabrication and characteristics of anti-inflammatory magnesium hydroxide incorporated PLGA scaffolds formed with various porogen materials , 2014, Macromolecular Research.
[4] N. Chen,et al. Interleukin-10 deficiency aggravates kidney inflammation and fibrosis in the unilateral ureteral obstruction mouse model , 2013, Laboratory Investigation.
[5] I. Dixon. Cardiac myofibroblasts: cells out of balance. A new thematic series , 2012, Fibrogenesis & tissue repair.
[6] T. Hewitson. Fibrosis in the kidney: is a problem shared a problem halved? , 2012, Fibrogenesis & tissue repair.
[7] S. Shi,et al. Mesenchymal Stem Cell-Based Tissue Regeneration is Governed by Recipient T Lymphocyte via IFN-γ and TNF-α , 2011, Nature Medicine.
[8] Hirenkumar K. Makadia,et al. Poly Lactic-co-Glycolic Acid ( PLGA ) as Biodegradable Controlled Drug Delivery Carrier , 2011 .
[9] Je-Yong Choi,et al. An acidic pH environment increases cell death and pro-inflammatory cytokine release in osteoblasts: the involvement of BAX inhibitor-1. , 2011, The international journal of biochemistry & cell biology.
[10] F. O'Brien. Biomaterials & scaffolds for tissue engineering , 2011 .
[11] D. Polak. The delivery of regenerative medicines and their impact on healthcare , 2010 .
[12] David L Kaplan,et al. Stem cell- and scaffold-based tissue engineering approaches to osteochondral regenerative medicine. , 2009, Seminars in cell & developmental biology.
[13] Paul Martin,et al. Inflammatory cells during wound repair: the good, the bad and the ugly. , 2005, Trends in cell biology.
[14] Chad Johnson,et al. The effect of scaffold degradation rate on three-dimensional cell growth and angiogenesis. , 2004, Biomaterials.
[15] Nuo Wang,et al. Synthesis, characterization, biodegradation, and drug delivery application of biodegradable lactic/glycolic acid polymers. Part II: Biodegradation , 2001, Journal of biomaterials science. Polymer edition.
[16] S. Ashley,et al. Interleukin-10 reduces circulating levels of serum cytokines in experimental pancreatitis , 1997, Journal of Gastrointestinal Surgery.
[17] E. Topol,et al. Marked inflammatory sequelae to implantation of biodegradable and nonbiodegradable polymers in porcine coronary arteries. , 1996, Circulation.
[18] D. Berg,et al. Interleukin-10 gene knock-out mice: a model of chronic inflammation. , 1995, Clinical Immunology and Immunopathology.
[19] T. Macdonald. Gastrointestinal Inflammation: Inflammatory bowel disease in knockout mice , 1994, Current Biology.
[20] K. Rajewsky,et al. Interleukin-10-deficient mice develop chronic enterocolitis , 1993, Cell.
[21] O D Rotstein,et al. Regulation of cytoplasmic pH in phagocytic cell function and dysfunction. , 1991, Clinical biochemistry.
[22] Fergal J. O'Brien,et al. Biomaterials and scaffolds for tissue engineering , 2011 .
[23] Todd C McDevitt,et al. Stem cell paracrine actions and tissue regeneration. , 2010, Regenerative medicine.
[24] A. Atala,et al. Regenerative medicine strategies for treatment of neurogenic bladder. , 2009, Therapy.